Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration

被引：0
|
作者：
Nalin Payakachat
Kent H. Summers
Andreas M. Pleil
Matthew M. Murawski
Joseph Thomas
Kristofer Jennings
James G. Anderson
机构：
[1] University of Arkansas for Medical Sciences,Division of Pharmaceutical Evaluation and Policy, Department of Pharmacy Practice, College of Pharmacy
[2] Endo Pharmaceuticals Inc.,Health Outcomes and PharmacoEconomics (HOPE)
[3] Pfizer,Worldwide Medical and Outcomes Research, Pfizer Global Pharmaceuticals
[4] Inc.,Department of Pharmacy Practice
[5] Purdue University School of Pharmacy,Department of Statistic
[6] Purdue University,Department of Sociology & Anthropology
[7] Purdue University,undefined
来源：
Quality of Life Research | 2009年 / 18卷
关键词：
Mapping; NEI-VFQ 25; EQ-5D; Low vision; Age-related macular degeneration (AMD); Quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：801 / 813
页数：12
相关论文
共 27 条
  • [1] Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration
    Payakachat, Nalin
    Summers, Kent H.
    Pleil, Andreas M.
    Murawski, Matthew M.
    Thomas, Joseph, III
    Jennings, Kristofer
    Anderson, James G.
    QUALITY OF LIFE RESEARCH, 2009, 18 (07) : 801 - 813
  • [2] Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D Utility Scores
    Kay, Stephen
    Ferreira, Alberto
    OPHTHALMIC EPIDEMIOLOGY, 2014, 21 (02) : 66 - 78
  • [3] Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Age-Related Macular Degeneration
    Khadka, Jyoti
    McAlinden, Colm
    Pesudovs, Konrad
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (03) : 1276 - 1276
  • [4] Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in Age-Related Macular Degeneration
    Orr, Peggy
    Rentz, Anne M.
    Margolis, Mary Kay
    Revicki, Dennis A.
    Dolan, Chantal M.
    Colman, Shoshana
    Fine, Jennifer T.
    Bressler, Neil M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (06) : 3354 - 3359
  • [5] Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25)
    Toprak, AB
    Eser, E
    Guler, C
    Baser, FE
    Mayali, H
    OPHTHALMIC EPIDEMIOLOGY, 2005, 12 (04) : 259 - 269
  • [6] Psychometric properties of the Croatian version of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25)
    Lesin Gacina, Dina
    Skegro, Bernarda
    Jandrokovic, Sonja
    Skegro, Ivan
    Beslic, Iva
    Bukvic, Marija
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (12) : 4025 - 4036
  • [7] Psychometric properties of the Croatian version of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25)
    Dina Lešin Gaćina
    Bernarda Škegro
    Sonja Jandroković
    Ivan Škegro
    Iva Bešlić
    Marija Bukvić
    International Ophthalmology, 2021, 41 : 4025 - 4036
  • [8] Persian Version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 39): A Validation Study
    Asgari, Soheila
    Hashemi, Hassan
    Nedjat, Saharnaz
    Shahnazi, Ashkan
    Fotouhi, Akbar
    IRANIAN JOURNAL OF OPHTHALMOLOGY, 2011, 23 (03): : 5 - 14
  • [9] Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population
    Jelin, Elma
    Wisloff, Torbjorn
    Moe, Morten C.
    Heiberg, Turid
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2019, 17 (01)
  • [10] Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population
    Elma Jelin
    Torbjørn Wisløff
    Morten C. Moe
    Turid Heiberg
    Health and Quality of Life Outcomes, 17
123